Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bandelow

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|November 21, 2015
Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controlsK R Engel, K Obst, B Bandelow, et al.
Deutsche Medizinische Wochenschrift (1946)|December 8, 2000
[Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome]S Heindl, C Binder, H Desel, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|February 7, 1998
[Value of sports in treatment of psychiatric illness]A Broocks, T F Meyer, A George, et al.
Anxiety|January 1, 1996
Cardio-respiratory and other symptom clusters in panic disorderB Bandelow, M Amering, O Benkert, et al.
Pharmacopsychiatry|November 9, 2000
The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trialB Bandelow, A Broocks, G Pekrun, et al.
The British Journal of Psychiatry. Supplement|October 1, 1992
Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modificationP Müller, B Bandelow, W Gaebel, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1990
Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, MunichB Bandelow, P Müller, W Gaebel, et al.
Neuroscience Letters|January 18, 2003
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismS Bleich, B Bandelow, K Javaheripour, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runnersA Broocks, T Meyer, A George, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 8, 2002
Clozapine-associated elevation of plasma cholinesteraseJ Wiltfang, B Schenk-Daprá, G Stiens, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
European Archives of Psychiatry and Clinical Neuroscience|November 21, 2015
Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controlsK R Engel, K Obst, B Bandelow, et al.
Deutsche Medizinische Wochenschrift (1946)|December 8, 2000
[Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome]S Heindl, C Binder, H Desel, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|February 7, 1998
[Value of sports in treatment of psychiatric illness]A Broocks, T F Meyer, A George, et al.
Anxiety|January 1, 1996
Cardio-respiratory and other symptom clusters in panic disorderB Bandelow, M Amering, O Benkert, et al.
Pharmacopsychiatry|November 9, 2000
The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trialB Bandelow, A Broocks, G Pekrun, et al.
The British Journal of Psychiatry. Supplement|October 1, 1992
Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modificationP Müller, B Bandelow, W Gaebel, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1990
Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, MunichB Bandelow, P Müller, W Gaebel, et al.
Neuroscience Letters|January 18, 2003
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismS Bleich, B Bandelow, K Javaheripour, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runnersA Broocks, T Meyer, A George, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 8, 2002
Clozapine-associated elevation of plasma cholinesteraseJ Wiltfang, B Schenk-Daprá, G Stiens, et al.
Pageof 8